High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.

In 96 ovarian cancer patients, the present study investigates the clinical significance of pretreatment concentrations of soluble CD44 standard (CD44s) and its isoforms v5 and v6 determined in the serum and the ascitic fluid by means of recently developed enzyme-linked immunosorbent assays (ELISAs)....

Descripción completa

Detalles Bibliográficos
Autores principales: Zeimet, A. G., Widschwendter, M., Uhl-Steidl, M., Müller-Holzner, E., Daxenbichler, G., Marth, C., Dapunt, O.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228203/
https://www.ncbi.nlm.nih.gov/pubmed/9413956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228203/
https://www.ncbi.nlm.nih.gov/pubmed/9413956

Ejemplares similares